期刊文献+

microRNA在非小细胞肺癌组织中的表达及其临床应用研究 被引量:16

A study on expression of microRNA in tissue of non-small cell lung cancer and its clinical application
下载PDF
导出
摘要 目的探讨microRNA(miRNA)在非小细胞肺癌(NSCLC)组织中的表达及其临床意义。方法用实时荧光定量PCR技术检测40例NSCLC患者癌组织与癌旁组织中miR-21、miR-20a、miR-31、miR-222、miR-223、miR-145、miR-126的表达变化。结果 NSCLC患者癌组织中miR-21、miR-20a、miR-31、miR-222较癌旁组织呈高表达(P<0.05),而miR-223、miR-145、miR-126呈低表达(P<0.05)。随着病情进展,miR-21、miR-222表达升高,miR-126表达下降。结论 miR-21、miR-20a、miR-31、miR-222、miR-145、miR-126、miR-223在NSCLC癌组织中表达存在差异,且miR-21、miR-222和miR-126与NSCLC病情的恶化发展相关,有助于预后判断。 Objective To detect and analyze the expression of microRNA(miRNA) in tissues of non-small cell lung cancer(NSCLS) by the real-time fluorescence quantitative PCR.Method The real-time fluorescence quantitative PCR was used to detect the expression of miR-21,miR-20a,miR-31,miR-222,miR-223,miR-145 and miR-126 in NSCLC tissues and the adjacent tissues from 40 cases.Results The expressions of miR-21,miR-20a,miR-31 and miR-222 were significantly higher in NSCLC tissues than those in adjacent tissues(P〈0.05),and the expressions of miR-223,miR-145 and miR-126 were significantly lower in NSCLC cancer tissues than those in adjacent tissues(P〈0.05).MiR-21 and miR-222 expressions increased with the progression of disease.The expression of miR-126 decreased with the progression of disease.Conclusion There were statistically significant differences of the expression of miR-21,miR-20a,miR-31,miR-222,miR-145 and miR-126 between NSCLC tissues and adjacent tissues.The expressions of miR-21,miR-222 and miR-126 were associated with the progression of disease development,so the detection showed very important diagnostic value and should be helpful for prognosis evaluation.
出处 《临床检验杂志》 CAS CSCD 北大核心 2011年第7期516-519,共4页 Chinese Journal of Clinical Laboratory Science
关键词 微小RNA 非小细胞肺癌 实时荧光定量PCR microRNA non-small cell lung cancer real-time fluorescence quantitative PCR
  • 相关文献

参考文献10

  • 1Liu X, Sempere LF, Ouyang H, et al. MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by re- pressing specific tumor suppressors [ J]. J Clin Invest, 2010, 120 (4) :1298-1309.
  • 2Hayashita Y, Osada H, Tatematsu Y, et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation [ J ]. Cancer Res, 2005,65 (21) :9628-9632.
  • 3Seike M, Goto A, Okano T, eta(. MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers [ J ]. Proc Natl Acad Sci USA, 2009,106 ( 29 ) : 12085 -12090.
  • 4Garofalo M, Di Leva G, Romano G, et al. miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 down-regulation[ J]. Cancer Cell, 2009,16 (6) :498-509.
  • 5Liu B, Peng XC, Zheng XL, et al. MiR-126 restoration downregu- late VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo[J]. Lung Cancer, 2009,66(2) :169-175.
  • 6辇伟奇,陈芳琳,敖绪军,陈正堂.miR-223在CXCR4^+ Lewis肺癌细胞中的显著低表达及其靶基因预测[J].第三军医大学学报,2009,31(22):2202-2205. 被引量:2
  • 7Shi B, Sepp-LorenzinoL, PriscoM, et al. MicroRNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells[J]. J Biol Chem, 2007,282(45 ) :32582-32590.
  • 8Livak K J, Sehmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2^-△△Ct method[ J]. Meth- ods, 2001,25(4) :402-408.
  • 9Garofalo M, Quintaballe C, Di Leva G, et al. MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer[J]. Onco- gene, 2008,27 ( 27 ) : 3845-3855.
  • 10Crawford M, Brawner E, Batte K, et al. MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines [ J ]. Biochem Biophy Res Commun, 2008,373 (4) :607-612.

二级参考文献16

  • 1厉红元,任国胜,谭金详.siRNA沉默人乳腺癌细胞株CXCR4基因的实验研究[J].第三军医大学学报,2007,29(8):728-730. 被引量:4
  • 2Garofalo M, Quintavalle C, Di-Leva G, et al. MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer[ J]. Oncogene,2008, 27(27): 3845-3855.
  • 3Su L, Zhang J, Xu H, et al. Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells[J]. Clin Cancer Res, 2005, 11 (23) : 8273 -8280.
  • 4Yu F, Yao H, Zhu P, et al. let-7 regulates self renewal and tumorigenicity of breast cancer cells [ J]. Cell, 2007, 131 (6) : 1109 - 1123.
  • 5Ma L, Teruya-Feidstein J, Weinberg R A. Tumor invasion and metastasis initiated by microRNA-10b in breast cancer[ J]. Nature, 2007, 449(7163) : 682 -688.
  • 6Blenkiron C, Goldstein L D, Thorne N P, et al. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype[J]. GenomeBiol, 2007, 8(10): R214.
  • 7Oonakahara K, Matsuyama W, Higashimoto I, et al. Stromal-derived factor-1 alpha/CXCL12-CXCR 4 axis is involved in the dissemination of NSCLC cells into pleural space[ J]. Am J Respir Cell Mol Biol, 2004, 30(5) : 671 -677.
  • 8Wagner P L, Hyjek E, Vazquez M F, et al. CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival[J]. J Thorac Cardiovasc Surg, 2009, 137(3) : 615 -621.
  • 9Reckamp K L, Figlin R A, Burdick M D, et al. CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer[ J]. BMC Cancer, 2009, 9 : 213.
  • 10Fazi F, Racanicchi S, Zardo G, et al. Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AMLI/ETO oncoprotcin [J]. Cancer Cell, 2007, 12(5):457-466.

共引文献1

同被引文献179

  • 1徐林,任涛,周涯,秦安东,郑静.微小RNA-7对人肺癌95D细胞体外增殖的作用[J].肿瘤,2010,30(9):763-767. 被引量:19
  • 2Landgren O, Waxman AJ. Multiple myeloma precursor disease [ J ]. JAMA, 2010,304(21 ) :2397-2404.
  • 3Vandenboom Ii TG, Li Y, Philip PA, et al. MicroRNA and cancer: tiny molecules with major implications [ J ]. Curt Genomics, 2008,9 (2) :97-109.
  • 4Garzon R, Calin GA, Croce CM. MicroRNAs in cancer[J]. Annu Rev Med ,2009,60 : 167-179.
  • 5Pichiorri F, Suh SS, Ladetto M, et al. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis [ J ]. Proc Natl Acad Sci USA, 2008,105 (35) : 12885-12890.
  • 6Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection[ J ]. Proc Natl Acad Sci USA, 2008,105 (30) : 10513-10518.
  • 7Resnick KE, Alder H, Hagan JP, et al. The detection of differenti- ally expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform[ J ]. Gynecol Oncol, 2009,112 (1) :55-59.
  • 8Pao W, Miller V, Zakowski M, et al. EGF receptor gene mutations are common in lung cancers from" never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib [ J ]. Proc Natl Acad Sci, 2004, 101 (36) :13306-13311.
  • 9Pao W, Wang TY, Riely GJ, et al. KRAS mutations and primary re- sistance of lung adenocarcinomas to gefitinib or erlotinib [ J ]. PLoS Med, 2005, 2(1):17.
  • 10Pandey J, Umphress SM, Kang Y, et al. Modulation of tumor induction and progression of oncogenic K-ras positive tumors in the pres- ence of TGF-131 haploinsufficiency[J]. Carcinogenesis, 2007, 28: 2589-2596.

引证文献16

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部